Quick Links: Skip to main page content
Skip to Search
Skip to Topics Menu
Skip to Common Links
U.S. Food & Drug Administration
Follow FDA
En Español
Search FDA
Home
Food
Drugs
Medical Devices
Radiation-Emitting Products
Vaccines, Blood & Biologics
Animal & Veterinary
Cosmetics
Tobacco Products
MAUDE Adverse Event Report: AMGEN INC. ON-BODY INJECTOR; NEULASTA
FDA Home
Medical Devices
Databases
-
510(k)
|
DeNovo
|
Registration & Listing
|
Adverse Events
|
Recalls
|
PMA
|
HDE
|
Classification
|
Standards
CFR Title 21
|
Radiation-Emitting Products
|
X-Ray Assembler
|
Medsun Reports
|
CLIA
|
TPLC
AMGEN INC. ON-BODY INJECTOR; NEULASTA
Back to Search Results
Health Effect - Clinical Code
No Information (3190)
Date of Event
08/28/2017
Type of Reportable Event
Serious Injury
Event or Problem Description
Neulasta on body injector fell off of patient at home.Dates of use: (b)(6)2017.Diagnosis or reason for use: drug induced neutropenia.
Search Alerts/Recalls
New Search
|
Submit an Adverse Event Report
Brand Name
ON-BODY INJECTOR
Common Device Name
NEULASTA
Manufacturer
(Section D)
AMGEN INC.
MDR Report Key
6839086
Report Number
MW5071911
Device Sequence Number
1121736
Product Code
NSC
Combination Product (Y/N)
N
Initial Reporter State
PA
Initial Reporter Country
US
Number of Events Summarized
1
Summary Report (Y/N)
N
Reporter Type
Voluntary
Initial Reporter Occupation
Nurse
Type of Report
Initial
Report Date
(Section B)
08/30/2017
1
Device was Involved in the Event
1
Patient was Involved in the Event
Is this an Adverse Event Report?
No
Is this a Product Problem Report?
Yes
Operator of Device
No Information
Was Device Available for Evaluation?
No
Initial Date Received by Manufacturer
Not provided
Initial Report FDA Received Date
09/01/2017
Patient Sequence Number
1
Outcome Attributed to Adverse Event
Required Intervention;
Patient Age
63 YR
Patient Weight
74
-
-